Skip to main contentAll people

Associate ProfessorNicholas Wilcken

Conjoint Associate Professor

Faculty of Medicine and Health

  • Conjoint Associate Professor
    Faculty of Medicine and Health

RESEARCH INTERESTs

Breast cancer treatment, clinical trials, systematic review, evidence based clinical practice guidelines.

FUNDED RESEARCH

  • GRANT
    Addressing the poor outcomes of young women with hormone receptor-positive, HER2-negative (HRHER2-) early breast cancer
    Department of Health and Aged Care (Federal - administered by NHMRC)1 Jan 2022
    People funded by this grant:
    • Fox SB,
    • Wilcken N,
    • Loi S,
    • Zdenkowski N,
    • McCarthy NJ
  • GRANT
    G03093 / Cochrane Round 8 Funding Program
    National Health and Medical Research Council (NHMRC)1 Jul 2020
    People funded by this grant:
    • Wilcken N
  • GRANT
    Cochrane Breast Cancer Group
    National Health and Medical Research Council (NHMRC)1 Jul 2017
    People funded by this grant:
    • Berber S,
    • Wilcken N,
    • Simes RJ,
    • Hickey B,
    • Saunders C
  • GRANT
    Phase II clinical trial of the PARP inhibitor, olaparib, in HR- deficient advanced breast and ovarian cancer in women without inherited BRCA1 or BRCA2 mutations
    Cancer Australia17 Apr 2017 - 16 Apr 2020
    People funded by this grant:
    • Mileshkin L,
    • Lee CK,
    • Scott C,
    • Wilcken N,
    • Sjoquist K
  • GRANT
    Randomised phase Ill trial of adjuvant radiotherapy versus observation following breast conserving surgery and endocrine therapy in patients with molecularly characterised low-risk luminal A early breast cancer
    National Health and Medical Research Council (NHMRC)1 Jan 2016 - 31 Dec 2021
    People funded by this grant:
    • Wilcken N,
    • Chua B
  • GRANT
    Cochrane Breast Cancer Group infrastructure funding for support and development of reliable and relevant systematic Cochrane reviews in breast cancer
    National Breast Cancer Foundation1 Jan 2014
    People funded by this grant:
    • Goodwin A,
    • Wilcken N
  • GRANT
    Randomised phase II trial of neoadjuvant chemotherapy +/- concurrent aromatase inhibitor endocrine therapy to down-stage large oestrogen receptor positive breast cancer
    National Health and Medical Research Council (NHMRC)1 Jan 2014
    People funded by this grant:
    • Wilcken N,
    • Francis P,
    • Boyle F,
    • Forbes J,
    • Murray N
  • GRANT
    Cochrane Breast Cancer group
    National Health and Medical Research Council (NHMRC)1 Jul 2013
    People funded by this grant:
    • Wilcken N
  • GRANT
    A Multi-site study of Tamoxifen dose escalation study in breast cancer patients with CYP2D6 polymorphisms (TADE study)
    National Health and Medical Research Council (NHMRC)1 Jan 2012
    People funded by this grant:
    • Balleine R,
    • Wilcken N,
    • Liddle C,
    • Gurney H
  • GRANT
    A novel approach to optimizing PARP inhibitor therapy in patients with triple negative and BRCA-associated breast cancer
    National Breast Cancer Foundation1 Jan 2011
    People funded by this grant:
    • Wilcken N,
    • Mitchell G,
    • Friedlander M
  • GRANT
    Cochrane Breast Cancer Group
    DHA1 Jan 2009
    People funded by this grant:
    • Wilcken N
  • GRANT
    The Cochrane Breast Cancer Group
    DHA1 Jul 2008
    People funded by this grant:
    • Wilcken N
  • GRANT
    Funding for Australian based cochrane collaberation activities: the cochrane breast cancer group
    DHA1 Jan 2005
    People funded by this grant:
    • Wilcken N
  • GRANT
    Systematic review of interventions for the management of locally advanced breast cancer
    Cure Cancer Australia Foundation1 Jan 2005
    People funded by this grant:
    • Ghersi D,
    • Wilcken N
  • GRANT
    Antidepressants and subjective well-being in advanced cancer: a double-blind randomised trial of Sertraline and St Johns Wort
    Cancer Council New South Wales1 Jan 2001
    People funded by this grant: